danalcock, Author at European Medical Journal - Page 3 of 15

A man wearing a VR headset

Virtual Reality: A New Treatment Modality – Part 2

Continuing the discussion on technology’s impact on healthcare, this episode also explores the gastrointestinal manifestations of COVID-19.

a doctor listening to a patient's heartbeat

Hypertrophic Cardiomyopathy: Exploring Long-Term Data and Real-World Experiences

A summary of the pathophysiology and clinical manifestations of hypertrophic cardiomyopathy is presented, followed by a discussion on the challenges in managing HCM.

Virtual Reality: A New Treatment Modality – Part 1

Focused on virtual reality’s use in healthcare, this episode explores the effects of virtual reality on the human mind.

Hypnosis: A Magical Tool in Clinical Scenarios – Part 2

In this second instalment, Sarah Partridge discusses success stories of hypnosis in a medical setting, and the potential benefits it provides to patient care.

A doctor conducting hypnotherapy with a patient

Hypnosis: A Magical Tool in Clinical Scenarios – Part 1

This episode explores the use of hypnosis in clinical practice and its impact managing side effects.

Gut Instincts: Bridging Psychology and Gastroenterology

Megan Riehl, health psychologist, discusses the management of gastrointestinal conditions such as IBS and IBD

A Personalised Approach to Diabetes

This episode explores self-management in diabetes and inequality in the field with Nick Oliver, Wynn Professor of Human Metabolism at Imperial College Healthcare NHS Trust.

Research in Diabetes: Inspiring Future Nurses

Maggie Shepherd discusses how we can strengthen the research influence of nurses, and inspire the next generation of nurses to pursue research in diabetes.

Unravelling Innovation: Advances in Genome Sequencing

In this episode, Madhuri Hegde, Senior Vice-President & Chief Scientific Officer at Revvity, Inc., discusses innovations in genomic testing and neuromuscular disorders

The Biodesign Blueprint: Decoding the Future of Medical Innovation

In this podcast, Joshua Makower, Stanford University, explores the world of biodesign and innovation to control rising healthcare costs